Drug helps delay progression of multiple sclerosis.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000075202:Contraindications; D018450:Disease Progression; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D008942:Mitoxantrone / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000517:prevention & control*
D000970:Antineoplastic Agents; D008942:Mitoxantrone